[1] TAC. ARV’s in our lives. A handbook for people living with HIV and treatment advocates in support groups, clinics and communities (http://www.tac.org.za/documents/arvsinourlives.pdf).
[2] Berger JR et al. Cranial neuropathy heralding otherwise occult AIDS-related large cell lymphoma. J Clin Neuroophthalmol 13: 113-18, 1993.
[3] Enting RH, Essenlink RA, Portegies R. Lymphomatous meningitis in AIDS-related systemic non-Hodgkin’s lymphoma: a report of eight cases. J Neurol Neurosurg Psychiatry 57:150-3, 1994.
[4] Andersson MI, Willcox PA. Tuberculous tenosynovitis and carpal tunnel syndrome as a presentation of HIV disease. J Infect.;39(3):240-1, 1999.
[5] Orrell R et al. Peripheral nerve granuloma in a patient with tuberculosis. J Neurol Neurosurg Psychiatry. 73(6): 769–771, 2002.
[6] Hernando I et al. Sensory-motor polyneuropathy associated with lung tuberculosis: presentation of two new cases]. Rev Neurol. 24(131):841-2, 1996.
[7] Nagel MA, Gilden DH. The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med. 74(7):489-94, 496, 498-9, 2007. (available online)
[8] Mueller NH et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin ;26(3):675-97, viii, 2008.
[9] Caniello M et al. Confluent peripheral multiple mononeuropathy associated to acute hepatitis B: a case report. Rev Inst Med Trop Sao Paulo;44(3):171-3, 2002.
[10] Heckmann JG et al. Neurological manifestations of chronic hepatitis C. J Neurol;246(6):486-91, 1999.
[11] Boukhris S et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. ;13(9):937-41, 2006.
[12] Louis E et al. Bilateral amyotrophic neuralgia (Parsonage Turner syndrome) with HIV seroconversion. Rev Neurol (Paris)159(6-7 Pt 1):685-7, 2003.
[13] Calabrese LH et al. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med 107:849-51, 1987.
[14] Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 252:633-41, 2005.
[15] Lipkin WI et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35:1479-83, 1985.
[16] Serrano P et al. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis.;44(6):e57-61, 2007.
[17] Bélec L et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol. 236(7):411-4, 1989.
[18] Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol. 12(6):450-1, 1991.
[19] Roullet E et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 44:2174-82, 1994.
[20] McCutchan JA. Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 21 (Suppl 2):S196-201, 1995.
[21] Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 5(Suppl 1):S33-6, 1992.
[22] Kolson DL, Gonzalez-Scarano F. HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst 6:2-7, 2001.
[23] Said G et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29:139-46, 1991.
[24] Kim YS et al. Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 17:32-37, 1993.
[25] Miller RF et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 61(5):456-60, 1996. (free online download).
[26] Winston A, Marriott D, Brew B. Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual. Sex Transm Infect 81(2):133-4 2005.
[27] Tajima Y, Sudo K Matumoto A, Malignant lymphoma originating in the cauda equina mimicking the Inflammatory polyradiculoneuropathy . Intern Med 46: 1029-1032, 2007. Free online download.
[28] Léger JM et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 239(3):132-4, 1992.
[29] Cornblath DR, McArthur JC. Predominant sensory neuropathy in patients with AIDS and AIDS related complex. Neurology 38:794-6, 1988.
[30] Cornblath DR, Griffin GW, Tennekoon, FI. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies. Ann Neuol 20:370-372, 1986.
[31] Thornton CA, Latif AS, Emmanuel JC. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology. 41(6):812-5, 1991.
[32] Simpson, D et al. HIV-associated neuromuscular weakness syndrome. AIDS. 18(10):1403-12, 2004.
[33] Vidal JE et al. HIV-associated neuromuscular weakness syndrome in Brazil: report of the two first cases. Arq Neuropsiquiatr;65(3B):848-51, 2007.
[34]Fredericks, EJ; Kugelman, TP; Kirsch, N. Dapsone-induced motor polyneuropathy. A complication of prolonged treatment of subcorneal pustular dermatosis. Arch Dermatol 112(8):1158–1160, 1976.
[35] Gutmann, L; Martin, JD; Welton, W. Dapsone motor neuropathy--an axonal disease. Neurology. Jun;26(6 Pt 1):514–516, 1976.
[36] Ahrens EM, Meckler RJ, Callen JP.Dapsone-induced peripheral neuropathy. Int J Dermatol 25(5):314-6, 1986.
[37] Keswani SC et al. The spectrum of peripheral neuropathies in AIDS. in The Neurology of AIDS, Editors, Gendelman HE et al. Edition: 2, illustrated, Oxford University Press, 2005.
[38] Verma S, Simpson DM. Peripheral neuropathy in HIV infection. Handb Clin Neurol ;85:129-37, 2007.
[39] Keswani, op cit.
[40] Spudich SS, Price RW. Neurological disease, in AIDS Therapy, 3rd Edition, Editors Dolan R, Masur H, Saag M. Churchill Livingstone, Elsevier Inc, 2008.
[41] Wu G et al. Early onset of spontaneous activity in uninjured C-fiber nociceptors after Injury to neighboring nerve fibers. The Journal of Neuroscience, 21:RC140:1-5, 2001.
[42] From, Brown RC et al. HIV/AIDS. Clinical Case Studies. 101 Cases for Training Clinical Staff. Nanasi, 2006.
[43] Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Periph. Nerv. Syst. 6: 14-20, 2001.
[44] Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9(2):153-61, 1995.
[45] Spudich, Price. Op cit.
[46] Keswani, op cit.
[47] Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol;19(5):481-6, 2006.
[48] Koike H et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Annals of Neurology, 54:1, 19 – 29, 2003.
[49] Williams FH. Neuromuscular complications of nutritional deficiencies. Phys Med Rehabil Clin N Am. 19(1):125-48, vii, 2008.
[50] Vinik AI, Mehrabyan A. Diabetic neuropathies.Med Clin North Am. 88(4):947-99, xi, 2004.
[51] Said G. Focal and multifocal diabetic neuropathies. Arq Neuropsiquiatr;65(4B):1272-8, 2007 (available online)
[52] Said G. Leprous neuropathy. In: Mendell JR, Kissel JT, Cornblath DR, eds. Diagnosis and management of peripheral nerve disorders. Oxford University Press: 551–64, 2001.
[53] Agrawal A et al. Neurological manifestations of Hansen's disease and their management. Clin Neurol Neurosurg. 107(6):445-54, 2005.
[54] Ooi WW, Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve. 30(4):393-409, 2004.
[55] Grimaud J, Vallat JM. [Neurological manifestations of leprosy [in French] Rev Neurol (Paris).159(11):979-95, 2003.
[56] Verma, Simspon, Op cit.
[57] Griffin JW et al. Predominantly sensory neuropathy in AIDS: distal axonal degeneration and unmyelinated fiber loss [abstract]. Neurology. 1991;41(suppl 1):374. Abstract 900S, 1991.
[58] Wiley CA. Neuromuscular diseases of AIDS. The FASEB Journal 3: 2503-2511, 1989.
[59] Verma, Simspon, op cit.
[60] Moyle GJ, Sadler M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf 19:481-494, 1998.
[61] Fichtenbaum CJ, Clifford DB, Powderly WG. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 10:169-174, 1995.
[62] So YT et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol 45(9):945-8, 1988.
[63] Schifitto G et al; Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 58(12):1764-8, 2002.
[64] Heaton R et al. HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 154, 2009.
[65] Ellis RJ et al. Persisting high prevalence of HIV distal sensory peripheral neuropathy in the era of combination ART: correlates in the CHARTER study. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 461, 2009.
[66] Evans SR et al. HIV-Associated peripheral neuropathy in the HAART era: results from AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Protocol A5001. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 462, 2009.
[67] Lichtenstein KA, Armon C, Baron A, et al, for the HIV Outpatient Study Investigators. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV Outpatient Study cohort. Clin Infect Dis. 40:148-157, 2005.
[68] Kallianpur AR et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 20(11)13 p 1503-1513, 2006.
[69] Costarelli S et al. No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. JAIDS 46(2)1 255-256, 2007.
[70] Cherry C et al. Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk. AIDS Research and Human Retroviruses. 24(2): 117-123, 2008.
[71] Hulgan T et al. Hemochromatosis gene polymorphisms, mitochondrial haplogroups and peripheral lipoatrophy during antiretroviral therapy. J Inf Dis197:858–866, 2008.
[72] Canter J et al. Mitochondrial sub-haplogroups and peripheral neuropathy during ART among non-Hispanic Black participants in AIDS Clinical Trials Group Study 384. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 160, 2009.
[73] Hulgan T et al. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19: 1341-1349, 2005.
[74] Mielke J. Peripheral nerve disease in HIV infected subjects, 2006. An African perspective. The Second assessment of NeuroAIDS in Africa. Arusha, Tanzania, 2006.
[75] Parry, O et al. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurologica Scandanavica 96(4) 218-222, 1997.
[76] Nakasujja N et al. Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol;11 Suppl 3:26-9, 2005.
[77] Sacktor N et al. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology;72(2):165-70, 2009.
[78] Forna F et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda J Acquir Immune Defic Syndr 2007;44:456–462, 2007.
[79] Birbeck GL, Am. J. Trop. Med. Hyg., in press.
[80] Boulle A et al. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther. 12(5): 753-60, 2007.
[81] Hitchcock SA, Meyer HP, Gwyther E. Neuropathic pain in AIDS patients prior to antiretroviral therapy. SAMJ 98 (11), 2008.
[82] Van Dyke RB et al. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 198:1599–608, 2008.
[83] Sithinamsuwan P et al. Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand. J Acquir Immune Defic Syndr 49(4), 2008.
[84] Cherry C et al. Predicting neuropathy risk before stavudine prescription: an algorithm for minimizing neurotoxicity in resource-limited settings. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 161, 2009.